EVEREST II REALISM - A Continued Access Study to Evaluate the Safety and Effectiveness of the MitraClip Device: Demographics and Procedural Outcomes - Laura Mauri, MD

↳ This is a section part of Moment: CRT 2015 Coronary - The iMPACT Trials: Session I

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$25.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

EVEREST II REALISM - A Continued Access Study to Evaluate the Safety and Effectiveness of the MitraClip Device: Demographics and Procedural Outcomes presented by Laura Mauri, MD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$25.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Interventional Cardiologists
Interventional Fellows

Session Name: The iMPACT Trials: Session I

Track: Coronary

Learning Objectives

Update in advances in Complex Coronary Intervention

Other Components in this Moment

Overview

EVEREST II REALISM - A Continued Access Study to Evaluate the Safety and Effectiveness of the MitraClip Device: Demographics and Procedural Outcomes - Laura Mauri, MD

Two Year Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) - Michael Haude, MD, PhD

Diamondback 360° Coronary Orbital Atherectomy System for Treating De Novo, Severely Calcified Lesions: 2-Year Results of the Pivotal ORBIT II Trial - Jeffrey W. Chambers, MD

Commentary on iMPACT Trials - Stephan Windecker, MD

Live Case Demonstration from Mount Sinai Medical Center - New York, NY

Keynote Lecture: the Five Best Trials from 2014 That May iMPACT My Practice - David R. Holmes Jr., MD

IVUS, NIRS and OCT: Which Should We Use and When? - Carlo Di Mario, MD

LM Coronary Stenting State of the Field: What Are We Doing in Europe? - Marie-Claude Morice, MD

Predicting the EXCEL Results From the SYNTAX Score II - P. Serruys, MD, PhD

Escalation in Hemodynamic Support - John M. Lasala, MD, PhD

Radial vs. Femoral Access in ACS Patients - Michael J. Cowley, MD

Live Case Demonstration From MedStar Washington Hospital Center - Washington, DC